Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × olaparib × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 23 Breast Neoplasms 21 Fallopian Tube Neoplasms 13 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 8 Neoplasms 6 Endometrial Neoplasms 6 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Stomach Neoplasms 3 Lymphoma, Non-Hodgkin 3 Glioma 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Osteosarcoma 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Glioblastoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1

Interventions

Cyclophosphamide 11 fludarabine 10 fludarabine phosphate 8 asciminib 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 Tacrolimus 6 Melphalan 5 Busulfan 5 nilotinib 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Dasatinib 4 Imatinib Mesylate 3 Filgrastim 3 olverembatinib 2 bosutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ruxolitinib 1 ponatinib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡